Cafepharma Daily Premium (On-Demand) Archive for August, 2018

Click a link below to view the mailing archive as if it had been sent to you.

2018-08-31 14:12		CP Friday Premium: CRISPR trial starting
2018-08-31 00:11		CP Thursday Evening Premium: Biotech IPOs on deck
2018-08-30 14:06		CP Thursday Premium
2018-08-30 00:03		CP Wednesday Evening Premium
2018-08-29 13:38		CP Wednesday Premium: Gilead's new Worldwide Commercial head comes from Amgen
2018-08-28 22:31		CP Tuesday Evening Premium: NAFTA
2018-08-28 13:25		CP Tuesday Premium: Gilead's UK rejection
2018-08-27 23:34		CP Monday Evening Premium: FDA actions
2018-08-27 12:15		CP Monday Premium: Tafamidis, Pfizer's next blockbuster?
2018-08-26 19:16		CP Sunday Premium
2018-08-25 23:33		CP Saturday Premium
2018-08-24 22:47		CP Friday Evening Premium
2018-08-24 13:02		CP Friday: a good day for HAE patients
2018-08-23 23:30		CP Thursday Evening Premium
2018-08-23 12:48		CP Thursday Premium: AZ disappoints with COPD trial
2018-08-22 23:25		CP Wednesday Evening Premium
2018-08-22 12:05		CP Wednesday Premium: FDA extends expirations on EpiPens
2018-08-21 23:29		CP Tuesday Evening Premium: Drug news and more
2018-08-21 12:58		CP Tuesday Premium: HHS Secretary Azar says they may stop drug rebates
2018-08-20 23:40		CP Monday Evening Premium: Drug news + first look at microbiome rpt
2018-08-20 13:28		CP Monday Premium: Jazz is hiring + biotech IPOs
2018-08-19 23:36		CP Sunday Premium
2018-08-18 17:54		CP Saturday Premium
2018-08-17 22:21		CP Friday Evening Premium
2018-08-17 12:21		CP Friday Premium: Bristol's Opdivo approved for SCLC
2018-08-17 00:09		CP Thursday Evening Premium: EpiPen generic approved
2018-08-16 14:02		CP Thursday Premium: Pain Therapeutics receives NIH grant
2018-08-15 23:44		CP Wednesday Evening Premium: Mustang Bio and more
2018-08-15 13:44		CP Wednesday Premium: Roche's Tecentriq for first line NSCLC
2018-08-15 00:18		CP Tuesday Evening Premium: PBM transparency?
2018-08-14 12:31		CP Tuesday Premium: IBM Watson Health pushes back against negative press
2018-08-14 00:52		CP Monday Evening Premium: The Chinese pharma market
2018-08-13 12:37		CP Monday Premium: FDA rejects BLA for Eylea
2018-08-12 13:22		CP Sunday Premium
2018-08-11 10:02		CP Friday Premium
2018-08-09 22:09		CP Thursday Evening Premium: PARP inhibitors and ALS
2018-08-09 13:49		CP Thursday Premium: FDA generic approvals hit all time high in July
2018-08-08 23:04		CP Wednesday Evening Premium: Humana suing generic drug companies
2018-08-08 12:29		CP Wednesday Premium: Trump changes his tone with drugmakers
2018-08-08 00:17		CP Tuesday Evening Premium
2018-08-07 13:34		CP Tuesday Premium: Alnylam plans a hiring spree
2018-08-07 00:32		CP Monday Evening Premium: CVS sues Pfizer
2018-08-06 14:45		CP Monday Premium: Regeneron and Bluebird teaming up on CAR-T
2018-08-05 19:28		CP Sunday Premium
2018-08-04 12:22		CP Saturday Premium
2018-08-04 00:28		CP Friday Evening Premium
2018-08-03 13:25		CP Friday Premium: Awaiting patisiran decision
2018-08-02 23:58		CP Thursday Evening Premium: Opioid news
2018-08-02 12:38		CP Thursday Premium: Teva earnings
2018-08-02 00:37		CP Wednesday Evening Premium
2018-08-01 12:53		CP Wednesday Premium: Sticker prices coming to drug ads?

<< Archive Index • Subscribe >>

Cafepharma Daily Premium (On-Demand) Archive for August, 2018

Contact Us

Past Issues

Unsubscribe